The molecular mechanisms of TLR-signaling cooperation in cytokine regulation

Immunology and Cell Biology

Volumn 94, Issue 6, 2016, Pages 538-542

  Liu, Qian ^a   Ding, Jeak Ling ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ENZYME REGULATION; HUMAN; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; AUTOCRINE EFFECT; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; METABOLISM;

ANIMALS; AUTOCRINE COMMUNICATION; CYTOKINES; HUMANS; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TRANSCRIPTION, GENETIC;

EID: 84960154302     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2016.18     Document Type: Review

References (43)

1. De Nardo D. Toll-like receptors: activation, signalling, and transcriptional modulation. Cytokine 2015; 74: 181-189
2. Takeuchi O, Akira S. Pattern recognition receptors, and inflammation. Cell 2010; 140: 805-820
3. Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007; 7: 179-190
4. Peters BM, Jabra-Rizk MA, O'May GA, Costerton JW, Shirtliff ME. Polymicrobial interactions: impact on pathogenesis, and human disease. Clin Microbiol Rev 2012; 25: 193-213
5. Whitmore MM, DeVeer MJ, Edling A, Oates RK, Simons B, Lindner D, et al. Synergistic activation of innate immunity by double-stranded RNA, and CpG DNA promotes enhanced antitumor activity. Cancer Res 2004; 64: 5850-5860
6. Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, et al. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. J Exp Med 2005; 201: 1435-1446
7. Napolitani G, Rinaldi A, Bertoni F, Sallusto F, Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol 2005; 6: 769-776
8. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses, and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005; 202: 1715-1724
9. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, et al. Toll-like receptors 9, and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 2004; 101: 3516-3521
10. Ferwerda G, Meyer-Wentrup F, Kullberg BJ, Netea MG, Adema GJ. Dectin-1 synergizes with TLR2, and TLR4 for cytokine production in human primary monocytes, and macrophages. Cell Microbiol 2008; 10: 2058-2066
11. Van Heel DA, Ghosh S, Butler M, Hunt K, Foxwell BM, Mengin-Lecreulx D, et al. Synergistic enhancement of Toll-like receptor responses by NOD1 activation. Eur J Immunol 2005; 35: 2471-2476
12. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, Caroff M, et al. Synergistic stimulation of human monocytes, and dendritic cells by Toll-like receptor 4, and NOD1-and NOD2-activating agonists. Eur J Immunol 2005; 35: 2459-2470
13. Uehara A, Yang S, Fujimoto Y, Fukase K, Kusumoto S, Shibata K, et al. Muramyldipeptide, and diaminopimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2-and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell Microbiol 2005; 7: 53-61
14. Tada H, Aiba S, Shibata K, Ohteki T, Takada H. Synergistic effect of Nod1, and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12, and T helper type 1 cells. Infect Immun 2005; 73: 7967-7976
15. Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S. Cutting edge: impaired Toll-like receptor expression, and function in aging. J Immunol 2002; 169: 4697-4701
16. Nyugen J, Agrawal S, Gollapudi S, Gupta S. Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 2010; 30: 806-813
17. Panda A, Qian F, Mohanty S, Van Duin D, Newman FK, Zhang L, et al. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 2010; 184: 2518-2527
18. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, et al. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 2011; 203: 1415-1424
19. Nimah M, Brilli RJ. Coagulation dysfunction in sepsis, and multiple organ system failure. Crit Care Clin 2003; 19: 441-458
20. Huang X, Hua J, Shen N, Chen S. Dysregulated expression of interleukin-23, and interleukin-12 subunits in systemic lupus erythematosus patients. Mod Rheumatol 2007; 17: 220-223
21. Kawai T, Akira S. Toll-like receptors, and their crosstalk with other innate receptors in infection, and immunity. Immunity 2011; 34: 637-650
22. Krummen M, Balkow S, Shen L, Heinz S, Loquai C, Probst HC, et al. Release of IL-12 by dendritic cells activated by TLR ligation is dependent on MyD88 signaling, whereas TRIF signaling is indispensable for TLR synergy. J Leukoc Biol 2010; 88: 189-199
23. Suet Ting Tan R, Lin B, Liu Q, Tucker-Kellogg L, Ho B, Leung BP, et al. The synergy in cytokine production through MyD88-TRIF pathways is co-ordinated with ERK phosphorylation in macrophages. Immunol Cell Biol 2013; 91: 377-387
24. Bagchi A, Herrup EA, Warren HS, Trigilio J, Shin HS, Valentine C, et al. MyD88-dependent, and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists. J Immunol 2007; 178: 1164-1171
25. Bekeredjian-Ding I, Roth SI, Gilles S, Giese T, Ablasser A, Hornung V, et al. T cellindependent, TLR-induced IL-12p70 production in primary human monocytes. J Immunol 2006; 176: 7438-7446
26. Tross D, Petrenko L, Klaschik S, Zhu Q, Klinman DM. Global changes in gene expression, and synergistic interactions induced by TLR9, and TLR3. Mol Immunol 2009; 46: 2557-2564
27. Arsenault RJ, Kogut MH, He H. Combined CpG, and poly I: C stimulation of monocytes results in unique signaling activation not observed with the individual ligands. Cell Signal 2013; 25: 2246-2254
28. Zhu Q, Egelston C, Vivekanandhan A, Uematsu S, Akira S, Klinman DM, et al. Toll-like receptor ligands synergize through distinct dendritic cell pathways to induce T cell responses: implications for vaccines. Proc Natl Acad Sci USA 2008; 105: 16260-16265
29. Bohnenkamp HR, Papazisis KT, Burchell JM, Taylor-Papadimitriou J. Synergism of Toll-like receptor-induced interleukin-12p70 secretion by monocyte-derived dendritic cells is mediated through p38 MAPK, and lowers the threshold of T-helper cell type 1 responses. Cell Immunol 2007; 247: 72-84
30. Makela SM, Strengell M, Pietila TE, Osterlund P, Julkunen I. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages, and dendritic cells. J Leukoc Biol 2009; 85: 664-672
31. Mitchell D, Yong M, Schroder W, Black M, Tirrell M, Olive C. Dual stimulation of MyD88-dependent Toll-like receptors induces synergistically enhanced production of inflammatory cytokines in murine bone marrow-derived dendritic cells. J Infect Dis 2010; 202: 318-329
32. Zhou L, Nazarian AA, Xu J, Tantin D, Corcoran LM, Smale ST. An inducible enhancer required for Il12b promoter activity in an insulated chromatin environment. Mol Cell Biol 2007; 27: 2698-2712
33. De Nardo D, De Nardo CM, Nguyen T, Hamilton JA, Scholz GM. Signaling crosstalk during sequential TLR4, and TLR9 activation amplifies the inflammatory response of mouse macrophages. J Immunol 2009; 183: 8110-8118
34. Smale ST. Selective transcription in response to an inflammatory stimulus. Cell 2010; 140: 833-844
35. Liu Q, Zhu Y, Yong WK, Sze NS, Tan NS, Ding JL. Cutting edge: synchronization of IRF1, JunB, and C/EBPbeta activities during TLR3-TLR7 cross-talk orchestrates timely cytokine synergy in the proinflammatory response. J Immunol 2015; 195: 801-805
36. Van Duin D, Mohanty S, Thomas V, Ginter S, Montgomery RR, Fikrig E, et al. Age-associated defect in human TLR-1/2 function. J Immunol 2007; 178: 970-975
37. Wu YW, Tang W, Zuo JP. Toll-like receptors: potential targets for lupus treatment. Acta Pharmacol Sin 2015; 36: 1395-1407
38. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147: 117-123
39. Daffis S, Suthar MS, Szretter KJ, Gale M Jr, Diamond MS. Induction of IFN-beta, and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3, and IRF-7. PLoS Pathog 2009; 5: e1000607
40. Suthar MS, Ma DY, Thomas S, Lund JM, Zhang N, Daffis S, et al. IPS-1 is essential for the control of West Nile virus infection, and immunity. PLoS Pathog 2010; 6: e1000757
41. Helmy M, Gohda J, Inoue J, Tomita M, Tsuchiya M, Selvarajoo K. Predicting novel features of Toll-like receptor 3 signaling in macrophages. PLoS ONE 2009; 4: e4661
42. Gutierrez J, St Laurent G 3rd, Urcuqui-Inchima S. Propagation of kinetic uncertainties through a canonical topology of the TLR4 signaling network in different regions of biochemical reaction space. Theor Biol Med Model 2010; 7: 7
43. Liu B, Liu Q, Yang L, Palaniappan SK, Bahar I, Thiagarajan PS, et al. Innate immune memory, and homeostasis may be conferred through TLR3-TLR7 pathway crosstalk. Sci. Signal. (In revision) 2016